Skip to content
10-K

Annual Report

REIN THERAPEUTICS, INC. RNTX

0001193125-26-126385

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 28.04M sh
Shares Diluted FY 2025 · Dec 31, 2025 25.44M sh
Shares Diluted FY 2025 · Dec 31, 2024 17.94M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$19.36M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$22.29M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.22M
Cash And Equivalents FY 2025 · Dec 31, 2024 $12.87M
Cash And Equivalents restated FY 2025 · Dec 31, 2023 $17.34M
Stockholders Equity FY 2025 · Dec 31, 2025 $16.92M
Stockholders Equity FY 2025 · Dec 31, 2024 $54.39M
Stockholders Equity restated FY 2025 · Dec 31, 2023 $98.3M
Current Liabilities FY 2025 · Dec 31, 2025 $6.18M
Current Liabilities FY 2025 · Dec 31, 2024 $5.75M
Total Liabilities FY 2025 · Dec 31, 2025 $7.24M
Total Liabilities FY 2025 · Dec 31, 2024 $7.8M
Current Assets FY 2025 · Dec 31, 2025 $4.33M
Current Assets FY 2025 · Dec 31, 2024 $13.66M
Total Assets FY 2025 · Dec 31, 2025 $24.16M
Total Assets FY 2025 · Dec 31, 2024 $62.19M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.96
Eps Diluted FY 2025 · Dec 31, 2024 −$3.51
Eps Basic FY 2025 · Dec 31, 2025 −$1.96
Eps Basic FY 2025 · Dec 31, 2024 −$3.51
Sga Expense FY 2025 · Dec 31, 2025 $10.9M
Sga Expense FY 2025 · Dec 31, 2024 $13.86M
Rd Expense FY 2025 · Dec 31, 2025 $11.03M
Rd Expense FY 2025 · Dec 31, 2024 $14.25M
Net Income FY 2025 · Dec 31, 2025 −$49.87M
Net Income FY 2025 · Dec 31, 2024 −$62.88M
Operating Income FY 2025 · Dec 31, 2025 −$50.63M
Operating Income FY 2025 · Dec 31, 2024 −$65.11M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0